Artículos relacionados a Life Expectancy In Cancer Survivors
Sinopsis
Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied.
"Sinopsis" puede pertenecer a otra edición de este libro.
Resultados de la búsqueda para Life Expectancy In Cancer Survivors
Imagen de archivo
Life Expectancy In Cancer Survivors (Paperback)
Impresión bajo demandaLibrería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Paperback. Condición: new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9786189451192
Comprar nuevo
EUR 12,42
Gastos de envío gratis
Se envía dentro de Estados Unidos de America
Se envía dentro de Estados Unidos de America
Cantidad disponible: 1 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors
Publicado por
Rashid Publications, 2026
ISBN 10: 6189451195
ISBN 13: 9786189451192
Nuevo
Tapa blanda
Librería: California Books, Miami, FL, Estados Unidos de America
Calificación del vendedor: 4 de 5 estrellas
Condición: New. Nº de ref. del artículo: I-9786189451192
Comprar nuevo
EUR 12,43
Gastos de envío gratis
Se envía dentro de Estados Unidos de America
Se envía dentro de Estados Unidos de America
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9786189451192
Comprar nuevo
EUR 13,41
Gastos de envío gratis
Se envía dentro de Estados Unidos de America
Se envía dentro de Estados Unidos de America
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9786189451192
Comprar nuevo
EUR 13,28
Envío por EUR 3,84
Se envía de Reino Unido a Estados Unidos de America
Se envía de Reino Unido a Estados Unidos de America
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors
Publicado por
Rashid Publications, 2026
ISBN 10: 6189451195
ISBN 13: 9786189451192
Nuevo
Tapa blanda
Librería: Majestic Books, Hounslow, Reino Unido
Calificación del vendedor: 4 de 5 estrellas
Condición: New. Print on Demand. Nº de ref. del artículo: 407553028
Comprar nuevo
EUR 14,48
Envío por EUR 7,58
Se envía de Reino Unido a Estados Unidos de America
Se envía de Reino Unido a Estados Unidos de America
Cantidad disponible: 4 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors
Publicado por
Rashid Publications, 2026
ISBN 10: 6189451195
ISBN 13: 9786189451192
Nuevo
Tapa blanda
Librería: Books Puddle, New York, NY, Estados Unidos de America
Calificación del vendedor: 4 de 5 estrellas
Condición: New. Nº de ref. del artículo: 26406682587
Comprar nuevo
EUR 18,99
Envío por EUR 3,44
Se envía dentro de Estados Unidos de America
Se envía dentro de Estados Unidos de America
Cantidad disponible: 4 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors
Publicado por
Rashid Publications, 2026
ISBN 10: 6189451195
ISBN 13: 9786189451192
Nuevo
Tapa blanda
Librería: Biblios, Frankfurt am main, HESSE, Alemania
Calificación del vendedor: 4 de 5 estrellas
Condición: New. PRINT ON DEMAND. Nº de ref. del artículo: 18406682577
Comprar nuevo
EUR 15,30
Envío por EUR 9,95
Se envía de Alemania a Estados Unidos de America
Se envía de Alemania a Estados Unidos de America
Cantidad disponible: 4 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors (Paperback)
Impresión bajo demandaLibrería: AussieBookSeller, Truganina, VIC, Australia
Calificación del vendedor: 5 de 5 estrellas
Paperback. Condición: new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Nº de ref. del artículo: 9786189451192
Comprar nuevo
EUR 19,62
Envío por EUR 31,90
Se envía de Australia a Estados Unidos de America
Se envía de Australia a Estados Unidos de America
Cantidad disponible: 1 disponibles
Imagen de archivo
Life Expectancy In Cancer Survivors (Paperback)
Impresión bajo demandaLibrería: CitiRetail, Stevenage, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Paperback. Condición: new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Nº de ref. del artículo: 9786189451192
Comprar nuevo
EUR 16,80
Envío por EUR 43,15
Se envía de Reino Unido a Estados Unidos de America
Se envía de Reino Unido a Estados Unidos de America
Cantidad disponible: 1 disponibles
Imagen del vendedor
Life Expectancy In Cancer Survivors
Publicado por
RASHID PUBLICATIONS, 2026
ISBN 10: 6189451195
ISBN 13: 9786189451192
Nuevo
Taschenbuch
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. Nº de ref. del artículo: 9786189451192
Comprar nuevo
EUR 13,65
Envío por EUR 60,45
Se envía de Alemania a Estados Unidos de America
Se envía de Alemania a Estados Unidos de America
Cantidad disponible: 2 disponibles